239 related articles for article (PubMed ID: 7543381)
1. Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model.
Silver MJ; Sutton JM; Hook S; Lee P; Malycky JL; Phillips ML; Ellis SG; Topol EJ; Nicolini FA
Circulation; 1995 Aug; 92(3):492-9. PubMed ID: 7543381
[TBL] [Abstract][Full Text] [Related]
2. Oxygen radical scavenging agents as adjuvant therapy with tissue plasminogen activator in a canine model of coronary thrombolysis.
Przyklenk K; Kloner RA
Cardiovasc Res; 1993 Jun; 27(6):925-34. PubMed ID: 8221780
[TBL] [Abstract][Full Text] [Related]
3. A novel sialyl LewisX analog attenuates neutrophil accumulation and myocardial necrosis after ischemia and reperfusion.
Lefer DJ; Flynn DM; Phillips ML; Ratcliffe M; Buda AJ
Circulation; 1994 Nov; 90(5):2390-401. PubMed ID: 7525107
[TBL] [Abstract][Full Text] [Related]
4. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
5. An oligosaccharide sialyl-Lewis(x) analogue does not reduce myocardial infarct size after ischemia and reperfusion in dogs.
Gill EA; Kong Y; Horwitz LD
Circulation; 1996 Aug; 94(3):542-6. PubMed ID: 8759100
[TBL] [Abstract][Full Text] [Related]
6. Conjunctive enhancement of enzymatic thrombolysis and prevention of thrombotic reocclusion with the selective factor Xa inhibitor, tick anticoagulant peptide. Comparison to hirudin and heparin in a canine model of acute coronary artery thrombosis.
Sitko GR; Ramjit DR; Stabilito II; Lehman D; Lynch JJ; Vlasuk GP
Circulation; 1992 Feb; 85(2):805-15. PubMed ID: 1735171
[TBL] [Abstract][Full Text] [Related]
7. Combination of platelet fibrinogen receptor antagonist and direct thrombin inhibitor at low doses markedly improves thrombolysis.
Nicolini FA; Lee P; Rios G; Kottke-Marchant K; Topol EJ
Circulation; 1994 Apr; 89(4):1802-9. PubMed ID: 8149546
[TBL] [Abstract][Full Text] [Related]
8. Recombinant soluble P-selectin glycoprotein ligand-Ig (rPSGL-Ig) attenuates infarct size and myeloperoxidase activity in a canine model of ischemia-reperfusion.
Wang K; Zhou X; Zhou Z; Tarakji K; Qin JX; Sitges M; Shiota T; Forudi F; Schaub RG; Kumar A; Penn MS; Topol EJ; Lincoff AM
Thromb Haemost; 2002 Jul; 88(1):149-54. PubMed ID: 12152656
[TBL] [Abstract][Full Text] [Related]
9. Infarct salvage with liposomal prostaglandin E1 administered by intravenous bolus immediately before reperfusion in a canine infarction-reperfusion model.
Smalling RW; Feld S; Ramanna N; Amirian J; Felli P; Vaughn WK; Swenson C; Janoff A
Circulation; 1995 Aug; 92(4):935-43. PubMed ID: 7641377
[TBL] [Abstract][Full Text] [Related]
10. Arterial diastolic pressure augmentation by intra-aortic balloon counterpulsation enhances the onset of coronary artery reperfusion by thrombolytic therapy.
Gurbel PA; Anderson RD; MacCord CS; Scott H; Komjathy SF; Poulton J; Stafford JL; Godard J
Circulation; 1994 Jan; 89(1):361-5. PubMed ID: 8281671
[TBL] [Abstract][Full Text] [Related]
11. The effect of CY1503, a sialyl Lewisx analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion.
Birnbaum Y; Patterson M; Kloner RA
J Mol Cell Cardiol; 1997 Aug; 29(8):2013-25. PubMed ID: 9281435
[TBL] [Abstract][Full Text] [Related]
12. Early thrombolysis by recombinant tissue-plasminogen activator is beneficial to the ischemic myocardium.
Higo K; Karasawa A; Kubo K
J Pharmacobiodyn; 1992 Jan; 15(1):33-7. PubMed ID: 1608039
[TBL] [Abstract][Full Text] [Related]
13. Myocardial neutrophil infiltration, lipid peroxidation, and antioxidant activity after coronary artery thrombosis and thrombolysis.
Chen LY; Nichols WW; Hendricks J; Mehta JL
Am Heart J; 1995 Feb; 129(2):211-8. PubMed ID: 7832091
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the platelet P2Y12 receptor by AR-C69931MX sustains coronary artery recanalization and improves the myocardial tissue perfusion in a canine thrombosis model.
Wang K; Zhou X; Zhou Z; Tarakji K; Carneiro M; Penn MS; Murray D; Klein A; Humphries RG; Turner J; Thomas JD; Topol EJ; Lincoff AM
Arterioscler Thromb Vasc Biol; 2003 Feb; 23(2):357-62. PubMed ID: 12588784
[TBL] [Abstract][Full Text] [Related]
15. Thrombolysis and reocclusion in experimental jugular vein and coronary artery thrombosis. Effects of a plasminogen activator inhibitor type 1-neutralizing monoclonal antibody.
Biemond BJ; Levi M; Coronel R; Janse MJ; ten Cate JW; Pannekoek H
Circulation; 1995 Feb; 91(4):1175-81. PubMed ID: 7850956
[TBL] [Abstract][Full Text] [Related]
16. Early intravenous administration of metoprolol enhances myocardial salvage by thrombolysis with recombinant tissue-type plasminogen activator after thrombotic coronary artery occlusion in the dog by improvement of the collateral blood flow to the area at risk.
Zmudka K; Aubert A; Dubiel J; Vanhaecke J; Flameng W; Kaczmarek J; De Geest H
J Am Coll Cardiol; 1994 May; 23(6):1499-504. PubMed ID: 8176113
[TBL] [Abstract][Full Text] [Related]
17. Enhanced thrombolysis, reduced coronary reocclusion and limitation of infarct size with liposomal prostaglandin E1 in a canine thrombolysis model.
Feld S; Li G; Amirian J; Felli P; Vaughn WK; Accad M; Tolleson TR; Swenson C; Ostro M; Smalling RW
J Am Coll Cardiol; 1994 Nov; 24(5):1382-90. PubMed ID: 7930264
[TBL] [Abstract][Full Text] [Related]
18. Single bolus administration of recombinant tissue plasminogen activator: effects on infarct related vessel patency, microvascular perfusion, and microvascular reocclusion in a canine model of thrombotic occlusion/reperfusion.
Longridge DJ; Follenfant MJ; Ford AJ
Cardiovasc Res; 1991 Mar; 25(3):184-91. PubMed ID: 1903080
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive treatment with ticagrelor, but not clopidogrel, added to tPA enables sustained coronary artery recanalisation with recovery of myocardium perfusion in a canine coronary thrombosis model.
Wang K; Zhou X; Huang Y; Khalil M; Wiktor D; van Giezen JJ; Penn MS
Thromb Haemost; 2010 Sep; 104(3):609-17. PubMed ID: 20694285
[TBL] [Abstract][Full Text] [Related]
20. Carbohydrate selectin inhibitor CY-1503 reduces neutrophil migration and reperfusion injury in canine pulmonary allografts.
Schmid RA; Yamashita M; Boasquevisque CH; Ando K; Fujino S; Phillips L; Cooper JD; Patterson GA
J Heart Lung Transplant; 1997 Oct; 16(10):1054-61. PubMed ID: 9361248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
